Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,115.00
+7.95 (0.72%)
At close: Jan 22, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 7.45 billion as of January 23, 2026. Its market cap has decreased by -22.25% in one year.
Market Cap
7.45B
Enterprise Value
8.53B
Revenue
3.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,115.00
Market Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 7.45B, an increase of 714.79%. That is a compound annual growth rate of 30.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 7.45B | -10.61% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 11.14B |
| Venus Remedies | 10.10B |
| Fermenta Biotech | 9.74B |
| Lincoln Pharmaceuticals | 9.24B |
| Anuh Pharma | 7.34B |
| Accent Microcell | 7.13B |
| Fredun Pharmaceuticals | 7.11B |
| Wanbury | 6.93B |